vs

Side-by-side financial comparison of AGILYSYS INC (AGYS) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $80.4M, roughly 1.0× AGILYSYS INC). AGILYSYS INC runs the higher net margin — 12.3% vs -38.1%, a 50.4% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 15.6%).

Agilysys Inc. is an American software company that develops and markets proprietary enterprise software and other products for the hospitality industry. The company specializes in point of sale, property management, inventory and procurement, document management, workforce management, and mobile and wireless products.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

AGYS vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.0× larger
PRCT
$83.1M
$80.4M
AGYS
Growing faster (revenue YoY)
PRCT
PRCT
+4.6% gap
PRCT
20.2%
15.6%
AGYS
Higher net margin
AGYS
AGYS
50.4% more per $
AGYS
12.3%
-38.1%
PRCT

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
AGYS
AGYS
PRCT
PRCT
Revenue
$80.4M
$83.1M
Net Profit
$9.9M
$-31.6M
Gross Margin
62.5%
64.9%
Operating Margin
14.6%
-4.1%
Net Margin
12.3%
-38.1%
Revenue YoY
15.6%
20.2%
Net Profit YoY
158.4%
-27.9%
EPS (diluted)
$0.35
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AGYS
AGYS
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$80.4M
$76.4M
Q3 25
$79.3M
$83.3M
Q2 25
$76.7M
$79.2M
Q1 25
$69.2M
Q4 24
$68.2M
Q3 24
$58.4M
Q2 24
$53.4M
Net Profit
AGYS
AGYS
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$9.9M
$-29.8M
Q3 25
$11.7M
$-21.4M
Q2 25
$4.9M
$-19.6M
Q1 25
$-24.7M
Q4 24
$-18.9M
Q3 24
$-21.0M
Q2 24
$-25.6M
Gross Margin
AGYS
AGYS
PRCT
PRCT
Q1 26
64.9%
Q4 25
62.5%
60.6%
Q3 25
61.7%
64.8%
Q2 25
61.7%
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
AGYS
AGYS
PRCT
PRCT
Q1 26
-4.1%
Q4 25
14.6%
-40.6%
Q3 25
17.8%
-27.8%
Q2 25
5.9%
-28.0%
Q1 25
-39.7%
Q4 24
-28.9%
Q3 24
-38.4%
Q2 24
-50.3%
Net Margin
AGYS
AGYS
PRCT
PRCT
Q1 26
-38.1%
Q4 25
12.3%
-39.1%
Q3 25
14.8%
-25.7%
Q2 25
6.4%
-24.7%
Q1 25
-35.8%
Q4 24
-27.6%
Q3 24
-35.9%
Q2 24
-48.0%
EPS (diluted)
AGYS
AGYS
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.35
$-0.54
Q3 25
$0.41
$-0.38
Q2 25
$0.17
$-0.35
Q1 25
$-0.45
Q4 24
$-0.34
Q3 24
$-0.40
Q2 24
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AGYS
AGYS
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$81.5M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$313.1M
$347.7M
Total Assets
$475.2M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AGYS
AGYS
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$81.5M
$286.5M
Q3 25
$59.3M
$294.3M
Q2 25
$55.6M
$302.7M
Q1 25
$316.2M
Q4 24
$333.7M
Q3 24
$196.8M
Q2 24
$214.1M
Total Debt
AGYS
AGYS
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
AGYS
AGYS
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$313.1M
$365.9M
Q3 25
$296.7M
$380.3M
Q2 25
$283.2M
$385.8M
Q1 25
$389.2M
Q4 24
$402.2M
Q3 24
$241.2M
Q2 24
$251.8M
Total Assets
AGYS
AGYS
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$475.2M
$508.1M
Q3 25
$425.6M
$511.5M
Q2 25
$426.0M
$513.1M
Q1 25
$519.4M
Q4 24
$534.0M
Q3 24
$374.1M
Q2 24
$374.4M
Debt / Equity
AGYS
AGYS
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AGYS
AGYS
PRCT
PRCT
Operating Cash FlowLast quarter
$23.3M
Free Cash FlowOCF − Capex
$22.7M
FCF MarginFCF / Revenue
28.3%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
2.35×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AGYS
AGYS
PRCT
PRCT
Q1 26
Q4 25
$23.3M
$-10.3M
Q3 25
$15.2M
$-6.6M
Q2 25
$-4.3M
$-15.0M
Q1 25
$-17.0M
Q4 24
$-32.4M
Q3 24
$-18.8M
Q2 24
$-15.7M
Free Cash Flow
AGYS
AGYS
PRCT
PRCT
Q1 26
Q4 25
$22.7M
$-12.2M
Q3 25
$15.0M
$-9.5M
Q2 25
$-5.0M
$-17.8M
Q1 25
$-18.8M
Q4 24
$-33.6M
Q3 24
$-19.0M
Q2 24
$-16.8M
FCF Margin
AGYS
AGYS
PRCT
PRCT
Q1 26
Q4 25
28.3%
-15.9%
Q3 25
18.9%
-11.4%
Q2 25
-6.5%
-22.5%
Q1 25
-27.2%
Q4 24
-49.2%
Q3 24
-32.6%
Q2 24
-31.4%
Capex Intensity
AGYS
AGYS
PRCT
PRCT
Q1 26
Q4 25
0.7%
2.4%
Q3 25
0.3%
3.4%
Q2 25
0.8%
3.5%
Q1 25
2.7%
Q4 24
1.7%
Q3 24
0.4%
Q2 24
2.0%
Cash Conversion
AGYS
AGYS
PRCT
PRCT
Q1 26
Q4 25
2.35×
Q3 25
1.30×
Q2 25
-0.89×
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AGYS
AGYS

Subscription And Maintenance$52.0M65%
Professional Services$17.7M22%
Products$10.7M13%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons